Status:

RECRUITING

Effect of Gelsectan® in the Treatment of Low Anterior Resection Syndrome

Lead Sponsor:

Istituto Clinico Humanitas

Conditions:

Low Anterior Resection Syndrome

Eligibility:

All Genders

18+ years

Brief Summary

Low Anterior Resection Syndrome (LARS) is an intestinal disorder affecting patients undergoing rectal resection for rectal cancer. A possible therapeutic option may be Gelsectan®, a class II device us...

Detailed Description

Low Anterior Resection Syndrome (LARS) affects almost 70% of patients after rectal resection for rectal cancer and is characterized by intestinal symptoms including urgency, fractioned defecation, and...

Eligibility Criteria

Inclusion

  • Patients aged more than 18 years old.
  • Patients who underwent low rectal resection for rectal cancer and who closed the ileostomy at least three months before the screening visit.
  • Patients with a LARS score ≥21 and/or clinically relevant symptoms of urgency, increased stool frequency, or fecal incontinence.
  • Patients indicated to treatment with Gelsectan® according to the clinical judgment.
  • Oncological chemotherapy or radiotherapy completed at least four weeks before the screening visit.
  • Presence of a functional, intact anastomosis.
  • Female patients of childbearing potential must agree to use a reliable method of contraception.

Exclusion

  • Known hypersensitivity to the investigational medicinal product (IMP).
  • Any condition that, in the opinion of the investigator, may interfere with the study procedures.
  • Significant anastomotic complications (e.g., strictures, fistula), which may impair the treatment efficacy.
  • Pregnant or breastfeeding women.
  • Inability to comply with the study procedures.

Key Trial Info

Start Date :

November 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 15 2025

Estimated Enrollment :

73 Patients enrolled

Trial Details

Trial ID

NCT06162143

Start Date

November 15 2023

End Date

November 15 2025

Last Update

January 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS Humanitas Research Hospital

Rozzano, MI, Italy, 20089